Revisiting coexisting chromosomal abnormalities in NPM1 -mutated AML in light of the revised ELN 2022 classification
Blood · 26.01.2023 · 141 (4) · 433-435
DOI: 10.1182/blood.2022018582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 26.01.2023. Verfasst von Linus Angenendt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine A, Münster University Hospital, Münster, Germany. Hauptthemen laut MEDLINE: Chromosome Aberrations, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Mutations in the nucleophosmin 1 gene (NPM1) occur frequently in acute myeloid leukemia (AML) and are associated with a favorable prognosis. Applying the new 2022 European LeukemiaNet (ELN) classifier, Angenendt et al tested the prognostic significance of the copresence of NPM1 mutations and adverse-risk cytogenetics among 2426 patients. The authors demonstrate that outcomes for cytogenetic adverse-risk AML are not modulated by the presence or absence of NPM1 mutations, thereby clarifying management for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine A, Münster University Hospital, Münster, Germany.
- Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
- Dresden University Hospital, Technical University Dresden, Dresden, Germany.
- Hospital Universitari i Politècnic La Fe, Valencia, Spain.
- Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
- The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID-Profile: Linus Angenendt, Christoph Röllig, Pau Montesinos, Christian Récher, Raphaël Itzykson, Andrew H Wei
Zitieren
APA
Angenendt, L., Röllig, C., Montesinos, P., Ravandi, F., Juliusson, G., Récher, C., Itzykson, R., Ráčil, Z., Wei, A. H., & Schliemann, C. (2023). Revisiting coexisting chromosomal abnormalities in NPM1 -mutated AML in light of the revised ELN 2022 classification. Blood, 141(4), 433-435. https://doi.org/10.1182/blood.2022018582
Vancouver
Angenendt L, Röllig C, Montesinos P, Ravandi F, Juliusson G, Récher C, et al. Revisiting coexisting chromosomal abnormalities in NPM1 -mutated AML in light of the revised ELN 2022 classification. Blood. 2023;141(4):433-435. doi:10.1182/blood.2022018582
BibTeX
@article{Angenendt2023,
author = {Angenendt, Linus and Röllig, Christoph and Montesinos, Pau and Ravandi, Farhad and Juliusson, Gunnar and Récher, Christian and Itzykson, Raphaël and Ráčil, Zdeněk and Wei, Andrew H and Schliemann, Christoph},
title = {Revisiting coexisting chromosomal abnormalities in NPM1 -mutated AML in light of the revised ELN 2022 classification},
journal = {Blood},
year = {2023},
volume = {141},
number = {4},
pages = {433--435},
doi = {10.1182/blood.2022018582}
}
EUVIMED